JP2016041705A5 - - Google Patents

Download PDF

Info

Publication number
JP2016041705A5
JP2016041705A5 JP2015196933A JP2015196933A JP2016041705A5 JP 2016041705 A5 JP2016041705 A5 JP 2016041705A5 JP 2015196933 A JP2015196933 A JP 2015196933A JP 2015196933 A JP2015196933 A JP 2015196933A JP 2016041705 A5 JP2016041705 A5 JP 2016041705A5
Authority
JP
Japan
Prior art keywords
agent according
day
nutritional composition
vitamin
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015196933A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016041705A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016041705A publication Critical patent/JP2016041705A/ja
Publication of JP2016041705A5 publication Critical patent/JP2016041705A5/ja
Pending legal-status Critical Current

Links

JP2015196933A 2009-09-14 2015-10-02 外因性ビタミンk2を含む炎症調節用栄養組成物 Pending JP2016041705A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US24208709P 2009-09-14 2009-09-14
US61/242,087 2009-09-14
US25084709P 2009-10-12 2009-10-12
US61/250,847 2009-10-12
US34794510P 2010-05-25 2010-05-25
US61/347,945 2010-05-25
US37184610P 2010-08-09 2010-08-09
US61/371,846 2010-08-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012528831A Division JP2013504572A (ja) 2009-09-14 2010-09-01 外因性ビタミンk2を含む炎症調節用栄養組成物

Publications (2)

Publication Number Publication Date
JP2016041705A JP2016041705A (ja) 2016-03-31
JP2016041705A5 true JP2016041705A5 (enExample) 2017-03-30

Family

ID=43098924

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012528831A Pending JP2013504572A (ja) 2009-09-14 2010-09-01 外因性ビタミンk2を含む炎症調節用栄養組成物
JP2012528830A Pending JP2013504571A (ja) 2009-09-14 2010-09-01 外因性ビタミンk2を含む栄養組成物
JP2015196933A Pending JP2016041705A (ja) 2009-09-14 2015-10-02 外因性ビタミンk2を含む炎症調節用栄養組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2012528831A Pending JP2013504572A (ja) 2009-09-14 2010-09-01 外因性ビタミンk2を含む炎症調節用栄養組成物
JP2012528830A Pending JP2013504571A (ja) 2009-09-14 2010-09-01 外因性ビタミンk2を含む栄養組成物

Country Status (17)

Country Link
US (5) US20130052274A1 (enExample)
EP (2) EP2477618A2 (enExample)
JP (3) JP2013504572A (enExample)
CN (2) CN102596190A (enExample)
AU (2) AU2010292439A1 (enExample)
BR (1) BR112012005783A2 (enExample)
CA (2) CA2773957C (enExample)
DK (1) DK2477510T3 (enExample)
ES (1) ES2669004T3 (enExample)
IN (2) IN2012DN02245A (enExample)
MX (2) MX2012003081A (enExample)
PH (2) PH12012500489A1 (enExample)
RU (2) RU2012114832A (enExample)
SG (2) SG179064A1 (enExample)
TR (1) TR201808128T4 (enExample)
WO (2) WO2011031601A2 (enExample)
ZA (2) ZA201202711B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130028864A1 (en) * 1998-04-08 2013-01-31 Theta Biomedical Consulting & Development Co., Inc. Anti-inflammatory compositions for treating brain inflammation
JP2013504572A (ja) * 2009-09-14 2013-02-07 ネステク ソシエテ アノニム 外因性ビタミンk2を含む炎症調節用栄養組成物
BR112013026706A2 (pt) * 2011-04-18 2016-12-27 Nestec Sa composições nutricionais compreendendo ácido alfa-hidroxi-isocaproico
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
CN102772401A (zh) * 2011-10-02 2012-11-14 南京大学 鼠尾草酚的抗骨质疏松新用途
WO2013144268A1 (en) * 2012-03-29 2013-10-03 Nestec S.A. Nutrition and exercise against drug-associated malnutrition in children
WO2013144267A2 (en) * 2012-03-29 2013-10-03 Nestec S.A. Improvement of musculoskeletal health by nutrition and exercise
BR112015001884B1 (pt) 2012-07-31 2020-12-01 Société des Produits Nestlé S.A. composição nutricional para promover a saúde musculoesquelética em pacientes com doença inflamatória intestinal (ibd), seu uso, e formulação farmacêutica, formulação nutricional, formulação de alimentação por tubo, suplemento alimentar, alimento funcional ou produto de bebida
US20150250839A1 (en) * 2012-09-11 2015-09-10 Dakota Star Capital Llc Nutritional supplement containing iron
CN103142640A (zh) * 2013-04-01 2013-06-12 李拖平 含有维生素k2的具有预防与治疗骨质疏松症的保健品
EP3397960B1 (en) * 2015-12-30 2020-01-29 Société des Produits Nestlé S.A. Method for determining fat free body mass
CN105815791B (zh) * 2016-03-24 2018-12-18 刘超 一种具有增肌功能并消除不良反应的组合物
AU2017274438A1 (en) * 2016-06-02 2018-12-13 Ana Pharmaceuticals, Inc. Methods and compositions for treatment of hypercalciuria and nephrolithiasis
US20220175851A1 (en) * 2019-03-13 2022-06-09 The Regents Of The University California Compositions, methods for regulating uterine, placental growth
CN110122866A (zh) * 2019-05-31 2019-08-16 广东双骏生物科技有限公司 一种慢性肾脏病血管钙化的特殊医学用途食品及制备方法
TR202002698A2 (tr) * 2020-02-21 2021-09-21 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Kemoterapi̇ ve/veya radyoterapi̇ alan ve/veya cerrahi̇ öncesi̇ ve
WO2023275183A1 (en) 2021-06-29 2023-01-05 Kappa Bioscience As Composition comprising vitamin k, vitamin d, xanthophyll and epa and/or dha
CN115989871A (zh) * 2021-10-20 2023-04-21 安琪纽特股份有限公司 一种促进生长发育的组合物及其制备方法和应用
CN115590198B (zh) * 2022-09-26 2024-06-18 黑龙江飞鹤乳业有限公司 核苷酸的用途、营养组合物、食品及其用途

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US347945A (en) 1886-08-24 vavtu
US242087A (en) 1881-05-24 Machine for making laps on belting
US371846A (en) 1887-10-18 Tennis-racket
US250847A (en) 1881-12-13 Vehicle-top
JPH07119191B2 (ja) * 1990-08-16 1995-12-20 株式会社日本触媒 メナジオン亜硫酸水素塩の安定化方法及びメナジオン亜硫酸水素塩組成物
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
EP0689835A3 (en) * 1994-06-30 1996-04-17 Ajinomoto Kk Composition containing an amino acid mixture and at least one N-3 fatty acid
WO1997039746A1 (en) * 1996-04-22 1997-10-30 Advanced Polymer Systems, Inc. Method of and composition for treating disorders of the skin using vitamin k
JP3459932B2 (ja) * 1996-07-23 2003-10-27 株式会社ホーネンコーポレーション 抗骨粗鬆症組成物
US6566064B1 (en) * 1999-05-18 2003-05-20 Nipro Corporation Method for anticipating sensitivity to medicine for osteoporosis
PT1153548E (pt) * 2000-05-12 2007-08-08 Nattopharma Asa Produto alimentar contendo vitamina k
NZ507335A (en) * 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
GB2370503A (en) * 2000-12-27 2002-07-03 Novartis Nutrition Ag Compositions comprising vitamin K
JP4131443B2 (ja) * 2001-08-27 2008-08-13 株式会社J−オイルミルズ 抗骨粗鬆症組成物
JP2004155658A (ja) * 2002-11-01 2004-06-03 Kyowa Hakko Kogyo Co Ltd TNF−α産生抑制剤
WO2005030190A1 (en) * 2003-09-26 2005-04-07 Natural Asa Natural menaquinone 7 compositions
WO2005107731A1 (ja) * 2004-05-12 2005-11-17 Eisai R & D Management Co., Ltd. ビタミンk2を有効成分として含む治療剤
CN102696941A (zh) * 2004-06-04 2012-10-03 视界科技有限公司 天然甜味剂
US20060223730A1 (en) * 2005-04-04 2006-10-05 Hl Distribution Company Calcium supplements
JP2006325487A (ja) * 2005-05-26 2006-12-07 Pola Chem Ind Inc 栄養補給用固形食品
US20090137614A1 (en) 2005-05-27 2009-05-28 Shionogi & Co., Ltd. Pharmaceutical combination comprising vitamin k
BE1016895A6 (fr) * 2005-12-16 2007-09-04 Psaltopoulos Emmanuel MOLECULE INCORPORANT LE CALCIUM (CA), LA VITAMINE "D" ET LA VITAMINE "K" POUR LA PREVENTION ET LE TRAITEMENT DE l'OSTEOPOROSE AINSI QUE POUR LA PREVENTION DE LA CALCIFICATION VASCULAIRE ET POUR LA PREVENTION DE LA CALCIFICATION DU CARTILAGE DES ARTICULATIONS.
CA2641315A1 (en) * 2006-02-06 2007-08-16 Tethys Bioscience, Inc. Osteoporosis associated markers and methods of use thereof
US9011930B2 (en) * 2006-05-01 2015-04-21 Zycal Bioceuticals Healthcare Company, Inc. Nutritional supplement and use thereof
WO2008006607A2 (en) * 2006-07-14 2008-01-17 Nattopharma Asa Pharmaceutical and nutraceutical products comprising vitamin k2
FR2906816B1 (fr) * 2006-10-04 2012-04-06 Gervais Danone Sa Variants de bacteries lactiques utiles pour produire la vitamine k2 et leurs applications a la preparation de produits alimentaires
US20080220094A1 (en) * 2006-11-01 2008-09-11 Wyeth Compositions and methods for the treatment and/or prevention of osteoporosis
BRPI0812686A2 (pt) * 2007-07-24 2011-10-18 Viridis Biopharma Pvt Ltd meios de aplicação de análogos da vitamina k e derivados para o tratamento de condições de doença humana e distúrbios
NL1034964C2 (nl) * 2008-01-28 2009-07-30 Friesland Brands Bv Werkwijze en composities voor de behandeling van botaandoeningen.
WO2009105234A2 (en) * 2008-02-19 2009-08-27 Combinatorx, Incorporated Methods and compositions for the treatment of disorders associated with defects of the cystic fibrosis transmembrane conductance regulator gene or protein
US8815953B2 (en) * 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
JP2013504572A (ja) * 2009-09-14 2013-02-07 ネステク ソシエテ アノニム 外因性ビタミンk2を含む炎症調節用栄養組成物

Similar Documents

Publication Publication Date Title
JP2016041705A5 (enExample)
Chikwanha et al. Nutritional enhancement of sheep meat fatty acid profile for human health and wellbeing
RU2012114832A (ru) Питательные композиции для модулирования воспаления, содержащие экзогенный витамин к2
RU2013146517A (ru) Композиции и способы, пригодные для облегчения возрастных заболеваний
Stamey et al. Use of algae or algal oil rich in n-3 fatty acids as a feed supplement for dairy cattle
Bhattacharya et al. Biological effects of conjugated linoleic acids in health and disease
Faber et al. Rapid EPA and DHA incorporation and reduced PGE2 levels after one week intervention with a medical food in cancer patients receiving radiotherapy, a randomized trial
JP2014515011A5 (enExample)
CL2020000804A1 (es) Productos protegidos dentro del rumen
TW200744463A (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
CA2660291A1 (en) Methods of improving bone health and muscle health
PH12015501751A1 (en) Nutritional compositions containing an enriched lipid fraction and uses thereof
PH12013501433A1 (en) High protein nutritional compositions and methods of making and using same
RU2015139359A (ru) Способ ослабления провоспалительной реакции
JP2021508343A (ja) リゾホスファチジルコリン組成物
PH12018500035A1 (en) Nutritional compositions and methods for promoting cognitive development
MX2016012694A (es) Composiciones nutritivas dirigidas a sujetos que tienen alergias a proteinas de la leche de vaca.
PH12018500036A1 (en) Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
EA201491489A1 (ru) Пищевая композиция, содержащая витамин k и насыщенный жир, и ее применение
CA2905817A1 (en) Reducing the risk of autoimmune disease
MX2019006464A (es) Nutrientes esenciales y metodos relacionados.
WO2015095570A3 (en) Nutritional composition comprising hydrolyzed protein
RU2015133023A (ru) Активация адипонектина с использованием гидролизата казеина
Virtanen Dietary polyunsaturated fat intake in coronary heart disease risk